Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network
暂无分享,去创建一个
L. Dagna | R. Manna | G. Merlini | A. Renieri | R. Giacomelli | R. Cimaz | A. Vitale | G. Emmi | G. Lopalco | B. Frediani | F. Iannone | D. Rigante | L. Cantarini | C. Salvarani | O. Viapiana | L. Obici | M. Piga | P. Ruscitti | M. Mencarelli | F. Caso | J. Hernández-Rodríguez | S. Grosso | A. Insalaco | L. L. Sicignano | E. Verrecchia | M. Maggio | A. Soriano | D. Montin | P. Parronchi | C. Gaggiano | M. Cattalini | M. A. Jaber | F. La Torre | J. Sota | V. Berlengiero | Luisa Ciarcia | Viviana Gelardi
[1] F. Nicolás-Sánchez,et al. p.RQ92 mutation associated with amyloidosis , 2021 .
[2] M. van Gijn,et al. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases , 2019, Annals of the rheumatic diseases.
[3] M. Sormani,et al. Classification criteria for autoinflammatory recurrent fevers , 2019, Annals of the rheumatic diseases.
[4] M. Swertz,et al. New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID) , 2018, Journal of Medical Genetics.
[5] L. Bezrodnik,et al. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry , 2017, Orphanet Journal of Rare Diseases.
[6] J. Yagüe,et al. Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene , 2017, Front. Immunol..
[7] Q. Yao,et al. Adult autoinflammatory disease frequency and our diagnostic experience in an adult autoinflammatory clinic. , 2016, Seminars in arthritis and rheumatism.
[8] S. Ozen,et al. International retrospective chart review of treatment patterns in severe FMF, TRAPS and MKD/HIDS , 2016 .
[9] J. Yagüe,et al. Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center. , 2016, Autoimmunity reviews.
[10] S. Ozen,et al. Development of the autoinflammatory disease damage index (ADDI) , 2016, Pediatric Rheumatology.
[11] M. Sormani,et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers , 2015, Annals of the rheumatic diseases.
[12] E. Silvestri,et al. Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome , 2014, Clinical Rheumatology.
[13] L. Punzi,et al. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. , 2014, Seminars in arthritis and rheumatism.
[14] I. Touitou,et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry , 2013, Annals of the rheumatic diseases.
[15] M. Galeazzi,et al. Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined. , 2013, Reumatismo.
[16] P. Hawkins,et al. AA amyloidosis complicating the hereditary periodic fever syndromes. , 2013, Arthritis and rheumatism.
[17] R. Cimaz,et al. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. , 2012, Autoimmunity reviews.
[18] I. Touitou,et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers , 2012, Annals of the rheumatic diseases.
[19] S. Bombardieri,et al. Validation of a Diagnostic Score for the Diagnosis of Autoinflammatory Diseases in Adults , 2011, International journal of immunopathology and pharmacology.
[20] M. Galeazzi,et al. Autoinflammatory diseases and cardiovascular manifestations , 2011, Annals of medicine.
[21] M. Sormani,et al. Long-Term Clinical Profile of Children With the Low-Penetrance R92Q Mutation of the TNFRSF1A Gene , 2011, Arthritis and rheumatism.
[22] J. Pouchot,et al. Extended Report , 2022 .
[23] C. Baldari,et al. Role of Etanercept in the Treatment of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Personal Experience and Review of the Literature , 2010, International journal of immunopathology and pharmacology.
[24] R. von Kries,et al. Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. , 2009, Rheumatology.
[25] N. Ravet,et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene , 2006, Annals of the rheumatic diseases.
[26] I. Touitou,et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients , 2006, Annals of the rheumatic diseases.
[27] G. Hitman,et al. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis , 2004, Genes and Immunity.
[28] D. Kastner,et al. The TNF Receptor-Associated Periodic Syndrome (TRAPS): Emerging Concepts of an Autoinflammatory Disorder , 2002, Medicine.
[29] J. Piette,et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. , 2002, Arthritis and rheumatism.
[30] D. Kastner,et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. , 2001, American journal of human genetics.
[31] Ian Todd,et al. Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.